Europe Archives - Page 36 of 93 - Journal for Clinical Studies

Current Edition

Europe

New Survey Finds Fragmented Processes and System Silos Slowing Clinical Trials

Sponsors and CROs accelerate move to modernize and speed study execution There is an industrywide drive to streamline trial processes and systems for better study ...

19 June 2019 Europe | news

Continue Reading →

Europe

Experimental drug delays Type 1 diabetes in research first

An experimental biologic drug appeared to substantially delay the development of Type 1 diabetes in people at high risk for the chronic condition, surprising results...

13 June 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication

Roche cancer drug Gazyva met its endpoint in a phase 2 lupus nephritis study, the company said. (Roche) One brand-new FDA approval and one trial win for its bloo...

13 June 2019 Europe | news | North America | Regional News

Continue Reading →

Asia Pacific

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

PCI secures third site for Clinical Trials storage, central logistics and distribution center Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a ...

6 June 2019 Asia Pacific | Europe | news | North America | Regional News

Continue Reading →

Europe

AbbVie unveils Venclexta data that scored lightning-fast leukemia combination nod

AbbVie's Venclexta-Gazyva combination joins its Imbruvica in the first-line CLL setting. (AbbVie) CHICAGO—Last month, partners AbbVie and Roche nabbed a spe...

6 June 2019 Europe | news | North America | Regional News

Continue Reading →

Asia Pacific

Research Point Global and WuXi CDS to rebrand as WuXi Clinical – a client-centric CRO – at DIA 2019

The newly combined CRO specializes in collaborative partnering for global clinical trials. The mid-sized CRO market has seen a number of significant changes, and now...

5 June 2019 Asia Pacific | Europe | news | North America | Regional News

Continue Reading →

Europe

Roche’s personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced positive data from the Phase I/II STARTRK-NG study, evaluating the investigational medicine entrectinib in children and ...

30 May 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Allergan puts Vraylar on blockbuster track with new bipolar depression nod

Credit Suisse analysts predict Allergan's Vraylar could hit $1.16 billion in sales by 2026. (Allergan) Allergan, badly in need of good news, finally has some to ...

30 May 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

No news is bad news for Tocagen

Tocagen said Tuesday its brain cancer trial has not been able to show so far that a combination therapy of experimental agents Toca 511 and Toca FC extended survi...

30 May 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Depression: Esketamine trial leaves ‘more questions than answers’

A phase 3 clinical trial testing esketamine nasal spray in the treatment of severe depression found the spray mostly safe and effective. The findings led to the rece...

23 May 2019 Europe | news | North America | Regional News

Continue Reading →